The average HaCaT cell count of the 5% PL group was significantly higher in the 11012cells/L treatment than that in the 21012cells/L treatment (P=0.01), irrespective of the passage frequency. == Table 3. and epidermal growth factor (EGF) were significantly higher in PL prepared from PC with a cell density of 21012/L than 11012/L PC. However, only VEGF and PDGF-AA concentrations in PLs were correlated with HaCaT cell counts. == Conclusions == The 5% PL from PC with a cell density of 11012/L prepared by two FT cycles treatment was the most effective condition that supported constant HaCaT cell proliferation. Our obtaining may be useful for preparing PL-supplemented cell culture media. Keywords:Platelet lysate, Cell culture, Freeze-thaw, Growth factor, Cell proliferation == INTRODUCTION == Discovery of the release of growth factors from platelets has triggered an interest in using platelet-rich plasma (PRP) for wound healing and tissue regeneration [1-4]. Recently, platelet lysates (PL) derived from PRP have been studied for their potential advantages as a replacement for using fetal bovine serum (FBS) in cell cultures [5-11]. Studies have shown that cells cultured in the presence of FBS or fetal calf serum (FCS), when injected into the human body, produce an immune response due to the animal nature of the sera utilized ABT 492 meglumine (Delafloxacin meglumine) for cultures [12]. In addition, FBS could potentially contain prions, and therefore may potentially transmit infectious diseases from animals. Platelet concentrates (PC) have the advantage of being relatively inexpensive since they are by-products of blood preparation. Most of the studies on using PL as an FBS replacement were focused onin vitroculture and growth of transplantable mesenchymal stromal ABT 492 meglumine (Delafloxacin meglumine) cells for cell therapy [5-10]. PLs have also been utilized for culturing adipose tissue-derived stem cells, fibroblasts, and osteoblasts [13-15]. However, you will find no requirements for the PL used during cell cultivation, Gja1 and each research has different methods of usage and production of PRP. Accordingly, it is difficult to find the best way to prepare PL in the laboratory. As the methods of generating PL involving the release of growth factors from platelet granules, PRP is usually activated either by adding the platelet agonists of thrombin and calcium chloride, or by repeating the freeze-thaw (FT) process. Even though former method is more effective to secrete granule from platelets than the latter method, the latter method is usually cost-effective, and the lysate can be conveniently stored. PL is also safe for use in humans since it is free from animal ABT 492 meglumine (Delafloxacin meglumine) products. Although PL has been utilized for culturing diverse cell types, including adult stem cells, a lack of standard protocols for preparing PL has prevented its widespread use as a replacement for animal sera [5-10,16]. Therefore, we sought to optimize the conditions for preparing PL as a substitute for FBS in cell culture. == METHODS == == 1. Preparation of platelet lysates == The study protocol was approved by the institutional review table of the Hanmaum Blood Center. PC that were discarded due to high ALT levels (>65 IU/L) were obtained from the Hanmaum Blood Center. The PC were prepared from whole blood by double centrifugation with citrate phosphate dextrose adenine-1 (CPDA-1; GCMS, Yongin, Korea) as an anticoagulant. PL was prepared by using the methods reported by Schallmoser et al. [5] and Lim et al. [17] with minor modifications. To eliminate the ABT 492 meglumine (Delafloxacin meglumine) specific effect of individual PC in each experiment, three to fourteen concentrates of identical ABO blood types generated by pooling were used. The PC were prepared within two days of collecting blood and were stored in a platelet agitator at 22. After thoroughly combining the pooled concentrates, platelet and white blood cell (WBC) counts were measured using an LH analyzer (Beckman Coulter, Fullerton, CA, USA). The pooled concentrates were then ABT 492 meglumine (Delafloxacin meglumine) centrifuged at 2,500 g for 10 min at room heat, the supernatant (platelet-poor plasma, PPP) was removed, and the final platelet counts were set at 11012/L and 21012/L, respectively. Three milliliters of each PPP was inoculated into Bactec PEDS PLUS (BD; Baltimore, MD, USA), and was analyzed for bacterial contamination for 5 days. Cell culture media and culture supernatants (spent.